Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
Clinical trial NCT03567720 · UNKNOWN
Trial details
- NCT number
- NCT03567720
- Sponsor
- OncoSec Medical Incorporated
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-11
- Primary completion
- 2024-04-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.